Ost-müük Outset Medical, Inc. - OM CFD
Lisa lemmikuks- Kokkuvõte
- Ajaloolised andmed
- Sündmused
- Tuluaruanne
- Bilanss
- Rahavood
- Omand
Kauplemistingimused
| Hinnavahe | 0.08 | ||||||||
|
Pika positsiooni ööpäeva tasu
Long position overnight fee
Mine platvormile | -0.024874% | ||||||||
|
Lühikese positsiooni ööpäeva tasu
Short position overnight fee
Mine platvormile | 0.002651% | ||||||||
| Ööpäeva tasu aeg | 21:00 (UTC) | ||||||||
| Min kauplemise kogus | 1 | ||||||||
| Valuuta | USD | ||||||||
| Tagatis | 20% | ||||||||
| Aktsiabörs | United States of America | ||||||||
| Kauplemise vahendustasu | 0% |
*Information provided by Capital.com
Võtmestatistika
| Eelmine sulgemine* | 18.26 |
| Avatud* | 18.46 |
| Aastane muutus* | -58.12% |
| Päeva ulatus* | 18.31 - 18.63 |
| 52 nädala ulatus | 11.41-48.71 |
| Keskmine maht (10 päeva) | 555.55K |
| Keskmine maht (3 kuud) | 11.62M |
| Turukapitalisatsioon | 891.76M |
| P/E suhtarv | -100.00K |
| Ringluses olevad aktsiad | 48.47M |
| Tulu | 115.38M |
| EPS | -3.38 |
| Dividendid (% kasumist) | N/A |
| Beeta | -100.00K |
| Järgmine tuluaruande kuupäev | May 2, 2023 |
Kõigi andmete allikas on Refinitiv, välja arvatud tärniga märgitud, kus *-ga andmed on esitanud Capital.com
- Last Week
- Last Month
- Last Year
- Last two Years
- Max
- Daily
- Weekly
- Monthly
| Date | Close | Sulgemishind | Change (%) | Avamishind | High | Low |
|---|---|---|---|---|---|---|
| Mar 31, 2023 | 18.35 | 0.08 | 0.44% | 18.27 | 18.70 | 18.27 |
| Mar 30, 2023 | 18.26 | -0.06 | -0.33% | 18.32 | 18.56 | 17.92 |
| Mar 29, 2023 | 18.21 | -0.50 | -2.67% | 18.71 | 18.81 | 18.05 |
| Mar 28, 2023 | 18.69 | 0.64 | 3.55% | 18.05 | 19.17 | 18.05 |
| Mar 27, 2023 | 19.13 | -0.14 | -0.73% | 19.27 | 19.53 | 18.68 |
| Mar 24, 2023 | 19.07 | 0.60 | 3.25% | 18.47 | 19.17 | 17.97 |
| Mar 23, 2023 | 18.79 | -2.20 | -10.48% | 20.99 | 21.12 | 18.54 |
| Mar 22, 2023 | 20.97 | -0.65 | -3.01% | 21.62 | 21.95 | 20.96 |
| Mar 21, 2023 | 21.87 | 0.29 | 1.34% | 21.58 | 22.40 | 21.58 |
| Mar 20, 2023 | 21.58 | 1.07 | 5.22% | 20.51 | 21.61 | 20.12 |
| Mar 17, 2023 | 20.89 | 0.92 | 4.61% | 19.97 | 21.59 | 19.83 |
| Mar 16, 2023 | 20.45 | 1.44 | 7.57% | 19.01 | 20.61 | 19.01 |
| Mar 15, 2023 | 19.84 | 0.77 | 4.04% | 19.07 | 19.90 | 19.07 |
| Mar 14, 2023 | 19.98 | -0.50 | -2.44% | 20.48 | 20.61 | 19.50 |
| Mar 13, 2023 | 19.97 | 0.00 | 0.00% | 19.97 | 20.70 | 19.47 |
| Mar 10, 2023 | 20.46 | -1.06 | -4.93% | 21.52 | 21.54 | 19.30 |
| Mar 9, 2023 | 22.06 | -0.28 | -1.25% | 22.34 | 23.04 | 22.04 |
| Mar 8, 2023 | 22.43 | -0.04 | -0.18% | 22.47 | 22.88 | 22.10 |
| Mar 7, 2023 | 22.63 | 0.14 | 0.62% | 22.49 | 23.08 | 22.47 |
| Mar 6, 2023 | 22.76 | -0.17 | -0.74% | 22.93 | 23.47 | 22.52 |
Outset Medical, Inc. Events
| Kellaaeg (UTC) (UTC) | Riik | Sündmus |
|---|---|---|
| No events scheduled | ||
- Aastas
- Kvartalis
| 2022 | 2021 | 2020 | 2019 | 2018 | |
|---|---|---|---|---|---|
| Kogutulu | 115.375 | 102.602 | 49.935 | 15.078 | 2.007 |
| Tulu | 115.375 | 102.602 | 49.935 | 15.078 | 2.007 |
| Kulud, Kokku | 97.542 | 94.994 | 62.972 | 32.88 | 8.122 |
| Brutokasum | 17.833 | 7.608 | -13.037 | -17.802 | -6.115 |
| Kogu tegevuskulu | 277.761 | 233.121 | 168.969 | 85.385 | 48.57 |
| Müük/Üldine/admin kulud, kokku | 129.997 | 101.386 | 75.58 | 29.178 | 17.532 |
| Uuringud ja arendus | 48.855 | 36.741 | 28.85 | 23.327 | 22.916 |
| Tulud majandustegevusest | -162.386 | -130.519 | -119.034 | -70.307 | -46.563 |
| Intressitulud (kulu), muud tulud, neto | -0.275 | -1.217 | -2.365 | -1.772 | -2.93 |
| Muud, neto | 0 | 0 | -0.093 | 3.8 | -0.262 |
| Netotulu enne makse | -162.661 | -131.736 | -121.492 | -68.279 | -49.755 |
| Netotulu pärast makse | -162.956 | -131.935 | -121.492 | -68.299 | -49.78 |
| Netotulu enne erikulusid | -162.956 | -131.935 | -121.492 | -68.299 | -49.78 |
| Netotulu | -162.956 | -131.935 | -121.492 | -68.299 | -49.78 |
| Total Adjustments to Net Income | 0 | 42.168 | -17.163 | -23.3 | |
| Arvestatav tulu, v a erikulud | -162.956 | -131.935 | -79.324 | -85.462 | -73.08 |
| Arvestatav tulu, koos erikuludega | -162.956 | -131.935 | -79.324 | -85.462 | -73.08 |
| Jaotamisele kuuluv netotulu | -162.956 | -131.935 | -79.324 | -85.462 | -73.08 |
| Keskmine jaotamisele kuuluv aktsia kohta | 48.161 | 45.589 | 42.722 | 45.2225 | 45.2225 |
| Jaotatav EPS, v a erakorralised kulud | -3.38357 | -2.89401 | -1.85675 | -1.88981 | -1.61601 |
| Dividends per Share - Common Stock Primary Issue | 0 | 0 | |||
| Jaotamisele kuuluv normaal-EPS | -3.36512 | -2.89401 | -1.82007 | -1.88981 | -1.61601 |
| Ootamatud kulutused (tulu) | 1.367 | 0 | 1.567 |
| Dec 2022 | Sep 2022 | Jun 2022 | Mar 2022 | Dec 2021 | |
|---|---|---|---|---|---|
| Kogutulu | 32.007 | 27.761 | 25.057 | 30.55 | 28.152 |
| Tulu | 32.007 | 27.761 | 25.057 | 30.55 | 28.152 |
| Kulud, Kokku | 26.734 | 23.425 | 21.275 | 26.108 | 24.831 |
| Brutokasum | 5.273 | 4.336 | 3.782 | 4.442 | 3.321 |
| Kogu tegevuskulu | 73.198 | 68.76 | 68.778 | 67.025 | 68.951 |
| Müük/Üldine/admin kulud, kokku | 33.653 | 32.276 | 33.982 | 30.086 | 32.71 |
| Uuringud ja arendus | 11.444 | 13.059 | 13.521 | 10.831 | 11.41 |
| Tulud majandustegevusest | -41.191 | -40.999 | -43.721 | -36.475 | -40.799 |
| Intressitulud (kulu), muud tulud, neto | -0.189 | 0.238 | -0.022 | -0.302 | -0.308 |
| Muud, neto | 0 | 0 | |||
| Netotulu enne makse | -41.38 | -40.761 | -43.743 | -36.777 | -41.107 |
| Netotulu pärast makse | -41.444 | -40.781 | -43.839 | -36.892 | -41.232 |
| Netotulu enne erikulusid | -41.444 | -40.781 | -43.839 | -36.892 | -41.232 |
| Netotulu | -41.444 | -40.781 | -43.839 | -36.892 | -41.232 |
| Total Adjustments to Net Income | 0 | ||||
| Arvestatav tulu, v a erikulud | -41.444 | -40.781 | -43.839 | -36.892 | -41.232 |
| Arvestatav tulu, koos erikuludega | -41.444 | -40.781 | -43.839 | -36.892 | -41.232 |
| Jaotamisele kuuluv netotulu | -41.444 | -40.781 | -43.839 | -36.892 | -41.232 |
| Keskmine jaotamisele kuuluv aktsia kohta | 49.139 | 48.129 | 47.882 | 47.487 | 43.6 |
| Jaotatav EPS, v a erakorralised kulud | -0.8434 | -0.84733 | -0.91556 | -0.77689 | -0.94569 |
| Dividends per Share - Common Stock Primary Issue | 0 | 0 | 0 | ||
| Jaotamisele kuuluv normaal-EPS | -0.82532 | -0.84733 | -0.91556 | -0.77689 | -0.94569 |
| Ootamatud kulutused (tulu) | 1.367 | 0 |
- Aastas
- Kvartalis
| 2021 | 2020 | 2019 | 2018 | |
|---|---|---|---|---|
| Käibevarad kokku | 409.802 | 345.911 | 79.646 | 147.646 |
| Raha ja lühiajalised investeeringud | 339.488 | 314.87 | 69.378 | 142.782 |
| Raha ja ekvivalendid | 182.348 | 294.972 | 36.226 | 33.264 |
| Lühiajalised investeeringud | 157.14 | 19.898 | 33.152 | 109.518 |
| Laekumata arved, neto | 25.6 | 6.468 | 3.914 | 1.088 |
| Accounts Receivable - Trade, Net | 25.6 | 6.468 | 3.914 | 1.088 |
| Total Inventory | 39.185 | 18.384 | 4.596 | 3.022 |
| Prepaid Expenses | 5.529 | 6.189 | 1.058 | 0.754 |
| Total Assets | 463.464 | 403.829 | 88.366 | 151.13 |
| Property/Plant/Equipment, Total - Net | 20.195 | 23.251 | 7.895 | 2.926 |
| Property/Plant/Equipment, Total - Gross | 27.849 | 28.239 | 10.565 | 5.149 |
| Accumulated Depreciation, Total | -7.654 | -4.988 | -2.67 | -2.223 |
| Other Long Term Assets, Total | 33.467 | 34.667 | 0.825 | 0.558 |
| Total Current Liabilities | 51.695 | 36.692 | 24.91 | 10.213 |
| Accounts Payable | 1.763 | 4.948 | 4.96 | 3.373 |
| Accrued Expenses | 39.575 | 26.578 | 10.43 | 5.349 |
| Notes Payable/Short Term Debt | 0 | 0 | 0 | 0 |
| Current Port. of LT Debt/Capital Leases | 0 | 7.509 | 0.01 | |
| Other Current Liabilities, Total | 10.357 | 5.166 | 2.011 | 1.481 |
| Total Liabilities | 89.383 | 75.22 | 51.107 | 46.796 |
| Total Long Term Debt | 29.762 | 29.674 | 21.561 | 28.355 |
| Long Term Debt | 29.762 | 29.674 | 21.561 | 28.346 |
| Capital Lease Obligations | 0 | 0.009 | ||
| Other Liabilities, Total | 7.926 | 8.854 | 4.636 | 8.228 |
| Total Equity | 374.081 | 328.609 | 37.259 | 104.334 |
| Redeemable Preferred Stock | 0 | 0 | 409.446 | 392.284 |
| Common Stock | 0.047 | 0.043 | 0.007 | 0.006 |
| Additional Paid-In Capital | 1000.21 | 822.624 | 0.356 | 0 |
| Retained Earnings (Accumulated Deficit) | -625.994 | -494.059 | -372.572 | -287.896 |
| Unrealized Gain (Loss) | -0.184 | 0.001 | 0.022 | -0.06 |
| Total Liabilities & Shareholders’ Equity | 463.464 | 403.829 | 88.366 | 151.13 |
| Total Common Shares Outstanding | 47.241 | 42.722 | 45.2225 | 45.2225 |
| Other Current Assets, Total | 0.7 |
| Mar 2022 | Dec 2021 | Sep 2021 | Jun 2021 | Mar 2021 | |
|---|---|---|---|---|---|
| Käibevarad kokku | 377.426 | 409.802 | 433.301 | 447.96 | 321.726 |
| Raha ja lühiajalised investeeringud | 302.267 | 339.488 | 373.043 | 396.208 | 277.484 |
| Raha ja ekvivalendid | 114.346 | 182.348 | 230.508 | 274.274 | 251.767 |
| Lühiajalised investeeringud | 187.921 | 157.14 | 142.535 | 121.934 | 25.717 |
| Laekumata arved, neto | 26.899 | 25.6 | 19.302 | 16.411 | 12.11 |
| Accounts Receivable - Trade, Net | 26.899 | 25.6 | 19.302 | 16.411 | 12.11 |
| Total Inventory | 42.873 | 39.185 | 34.297 | 28.882 | 24.554 |
| Prepaid Expenses | 5.387 | 5.529 | 6.659 | 6.459 | 7.578 |
| Total Assets | 431.742 | 463.464 | 488.804 | 504.813 | 379.829 |
| Property/Plant/Equipment, Total - Net | 20.844 | 20.195 | 22.026 | 23.027 | 23.552 |
| Other Long Term Assets, Total | 33.472 | 33.467 | 33.477 | 33.826 | 34.551 |
| Total Current Liabilities | 48.89 | 51.695 | 41.405 | 35.443 | 34.82 |
| Accounts Payable | 5.149 | 1.763 | 2.702 | 2.364 | 6.651 |
| Accrued Expenses | 30.789 | 39.575 | 29.861 | 23.573 | 22.295 |
| Notes Payable/Short Term Debt | 0 | 0 | 0 | 0 | 0 |
| Other Current Liabilities, Total | 12.952 | 10.357 | 8.842 | 9.506 | 5.874 |
| Total Liabilities | 86.289 | 89.383 | 79.053 | 73.651 | 73.184 |
| Total Long Term Debt | 29.784 | 29.762 | 29.74 | 29.718 | 29.696 |
| Long Term Debt | 29.784 | 29.762 | 29.74 | 29.718 | 29.696 |
| Other Liabilities, Total | 7.615 | 7.926 | 7.908 | 8.49 | 8.668 |
| Total Equity | 345.453 | 374.081 | 409.751 | 431.162 | 306.645 |
| Redeemable Preferred Stock | 0 | 0 | 0 | 0 | |
| Common Stock | 0.048 | 0.047 | 0.047 | 0.046 | 0.043 |
| Additional Paid-In Capital | 1008.94 | 1000.21 | 994.486 | 985.436 | 830.694 |
| Retained Earnings (Accumulated Deficit) | -662.886 | -625.994 | -584.762 | -554.292 | -524.084 |
| Unrealized Gain (Loss) | -0.649 | -0.184 | -0.02 | -0.028 | -0.008 |
| Total Liabilities & Shareholders’ Equity | 431.742 | 463.464 | 488.804 | 504.813 | 379.829 |
| Total Common Shares Outstanding | 47.712 | 47.241 | 47.018 | 46.225 | 42.888 |
- Aastas
- Kvartalis
| 2022 | 2021 | 2020 | 2019 | 2018 | |
|---|---|---|---|---|---|
| Netotulu/algväärtus | -162.956 | -131.935 | -121.492 | -68.299 | -49.78 |
| Raha majandustegevusest | -145.729 | -130.264 | -99.015 | -70.292 | -46.442 |
| Raha majandustegevusest | 5.169 | 5.162 | 3.159 | 1.484 | 1.069 |
| Mittelikviidsed varad | 33.2 | 22.112 | 25.167 | -1.878 | 2.486 |
| Cash Taxes Paid | 0.385 | 0.083 | 0.019 | 0.035 | 0.009 |
| Muutused tööjõus | -21.142 | -25.603 | -5.849 | -1.599 | -0.217 |
| Tulu investeeringutelt | -66.295 | -142.507 | 3.947 | 74.297 | -68.776 |
| Kapitalikulutused | -8.325 | -3.108 | -9.108 | -3.293 | -1.766 |
| Muud rahavood investeeringutelt, kokku | -57.97 | -139.399 | 13.055 | 77.59 | -67.01 |
| Rahavood investeeringutelt | 72.898 | 160.147 | 385.682 | 0.249 | 134.872 |
| Rahavoogudesse investeerimine | -0.181 | 0 | |||
| Aktsiate emiteerimine (tagasiost), neto | 8.042 | 160.147 | 387.046 | 0.439 | 134.881 |
| Laenu väljastamine (kustutamine), neto | 64.856 | 0 | -1.364 | -0.009 | -0.009 |
| Rahaline kogumuutus | -139.126 | -112.624 | 290.614 | 4.254 | 19.654 |
| Dec 2022 | Sep 2022 | Jun 2022 | Mar 2022 | Dec 2021 | |
|---|---|---|---|---|---|
| Net income/Starting Line | -162.956 | -121.512 | -80.731 | -36.892 | -131.935 |
| Cash From Operating Activities | -145.729 | -111.222 | -76.91 | -38.335 | -130.264 |
| Cash From Operating Activities | 5.169 | 3.9 | 2.586 | 1.262 | 5.162 |
| Non-Cash Items | 33.2 | 23.826 | 15.118 | 6.581 | 22.112 |
| Cash Taxes Paid | 0.385 | 0.334 | 0.283 | 0.205 | 0.083 |
| Changes in Working Capital | -21.142 | -17.436 | -13.883 | -9.286 | -25.603 |
| Cash From Investing Activities | -66.295 | -14.547 | -34.706 | -33.39 | -142.507 |
| Capital Expenditures | -8.325 | -6.216 | -3.475 | -1.478 | -3.108 |
| Other Investing Cash Flow Items, Total | -57.97 | -8.331 | -31.231 | -31.912 | -139.399 |
| Cash From Financing Activities | 72.898 | 7.298 | 4.765 | 3.723 | 160.147 |
| Issuance (Retirement) of Stock, Net | 8.042 | 7.433 | 4.765 | 3.723 | 160.147 |
| Issuance (Retirement) of Debt, Net | 64.856 | 0 | |||
| Net Change in Cash | -139.126 | -118.471 | -106.851 | -68.002 | -112.624 |
| Financing Cash Flow Items | -0.135 |
| Investori nimi | Investori liik | Ringluse protsent | Hoitud osakud | Muutus osakutes | Hoidmise kuupäev | Hinnang käibele |
|---|---|---|---|---|---|---|
| Fidelity Management & Research Company LLC | Investment Advisor | 14.9006 | 7221596 | 43587 | 2022-12-31 | LOW |
| The Vanguard Group, Inc. | Investment Advisor/Hedge Fund | 9.4361 | 4573186 | 88511 | 2022-12-31 | LOW |
| T. Rowe Price Investment Management, Inc. | Investment Advisor | 7.2627 | 3519870 | 346744 | 2022-12-31 | MED |
| BlackRock Institutional Trust Company, N.A. | Investment Advisor | 6.4729 | 3137096 | 187065 | 2022-12-31 | LOW |
| Bellevue Asset Management AG | Investment Advisor | 5.8675 | 2843679 | 426223 | 2022-12-31 | LOW |
| JP Morgan Asset Management | Investment Advisor | 5.295 | 2566216 | -605442 | 2022-12-31 | LOW |
| Champlain Investment Partners, LLC | Investment Advisor | 3.8387 | 1860405 | -79180 | 2022-12-31 | LOW |
| JPMorgan Asset Management U.K. Limited | Investment Advisor/Hedge Fund | 3.7342 | 1809787 | 67378 | 2022-12-31 | LOW |
| Braidwell LP | Hedge Fund | 3.5171 | 1704552 | 1704552 | 2022-12-31 | |
| Mubadala Investment Company PJSC | Sovereign Wealth Fund | 2.9808 | 1444665 | -1445678 | 2021-12-07 | LOW |
| Eagle Health Investments LP | Hedge Fund | 2.5185 | 1220609 | -17381 | 2022-12-31 | MED |
| State Street Global Advisors (US) | Investment Advisor/Hedge Fund | 2.4196 | 1172675 | -82108 | 2022-12-31 | LOW |
| Perceptive Advisors LLC | Private Equity | 2.2479 | 1089427 | -79203 | 2022-12-31 | MED |
| C WorldWide Asset Management Fondsmaeglerselskab A/S | Investment Advisor | 2.0633 | 1000000 | 0 | 2022-12-31 | LOW |
| RTW Investments L.P. | Investment Advisor/Hedge Fund | 1.8769 | 909652 | 0 | 2022-12-31 | LOW |
| Geode Capital Management, L.L.C. | Investment Advisor/Hedge Fund | 1.827 | 885478 | 20886 | 2022-12-31 | LOW |
| MFS Investment Management | Investment Advisor/Hedge Fund | 1.4675 | 711242 | 2265 | 2022-12-31 | LOW |
| Jennison Associates LLC | Investment Advisor/Hedge Fund | 1.2591 | 610224 | -350507 | 2022-12-31 | LOW |
| Mellon Investments Corporation | Investment Advisor/Hedge Fund | 1.2455 | 603635 | -25921 | 2022-12-31 | LOW |
| Fiera Capital Corporation | Investment Advisor/Hedge Fund | 1.1775 | 570660 | -829 | 2022-12-31 | LOW |
Miks valida Capital.com? Meie numbrid räägivad iseenda eest.
Capital.com Group500K+
Kauplejad
92K+
Igakuiste aktiivsete klientide arv
$53M+
Igakuine investeerimise maht
$30M+
Igakuiselt välja võetud
Kauplemiskalkulaator
Arvutage oma hüpoteetiline võit/kaotus, kui oleksite avanud CFD-tehingu ühel kindlal kuupäeval (valige kuupäev) ja sulgenud teisel kuupäeval (valige kuupäev).
Kauplemise vahendustasu
0
- 1:1
Finantsvõimendus
1:1
- 20
- 100
- 500
- 1000
- 10000
Investeering
Tehingu suurus (võimendus x investeering):
Avamishind
Close
Lühike Pikk
Outset Medical, Inc. Company profile
Ettevõttest Outset Medical, Inc.
Outset Medical, Inc. on meditsiinitehnoloogia ettevõte, mis pakub Tablo. Tablo on mobiilne integreeritud hemodialüüsi lahendus akuutseks ja koduseks hemodialüüsiraviks. Vee puhastamise ja tellitava dialüsaadi tootmise integreerimine võimaldab Tablo'l toimida dialüüsikliinikuna ratastel ja võimaldab teenuseosutajatel kasutada ühtset platvormi haiglast koju. Tablo kassett on ühekordselt kasutatav tarbekaup, mis on mõeldud patsientide kehavälise verepuhastuse hõlbustamiseks ja koosneb eelkonfigureeritud vere-, soolalahuse- ja infusioonitorustikust. Tablo puuteekraaniga paneel võimaldab kasutajal navigeerida ravi läbi animatsioonide ja mitte-tehnilise keele abil, mis on kohandatud nii professionaalsetele kui ka mitteprofessionaalsetele kasutajatele. Tablo pilvühenduse tarkvara võimaldab masina diagnostika ja analüüsi, raviõpetuse, jälgimise ja aruandluse, täiustatud dokumentatsiooni ning masina kaugjuhtimise ökosüsteemi. Lisaks pakub Tablo ka tugevat kliinilist hooldust.
| Industry: | Advanced Medical Equipment & Technology (NEC) |
3052 Orchard Drive
SAN JOSE
CALIFORNIA 95134
US
Tuluaruanne
- Annual
- Quarterly
Teised on vaadanud veel
Kas otsite jätkuvalt vahendajat, keda saab usaldada?
Ühinege 500,000+ kauplejaga üle kogu maailma, kes valisid kauplemiseks veebisaidi Capital.com